In the United States, breakthrough reimbursement for PET scans was determined by the

Question

Quizplus · Accepted Answer

In 1998, the CMS announced that FDG PET scans would be reimbursed for patients with solitary pulmonary nodules or non-small-cell lung cancer.This breakthrough in reimbursement opened the door for Medicare payments for patients with other cancers in which experience had shown that PET was the most accurate imaging technique for identifying and staging the disease.Reimbursement coverage has now been extended to melanoma, lymphoma, colorectal, head/neck, esophageal, recurrent breast cancers, and thyroid carcinoma.Private insurance companies may cover FDG PET studies in other types of cancer, usually after a thorough review of individual patient needs and circumstances.However, insurance carriers usually require preauthorization for any PET examination.

In the United States, Breakthrough Reimbursement for PET Scans Was